AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29453431 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (HC) infants
Number of subjects: 0
Study 27004631 — intervention group
Group type: EXPERIMENTAL
Intervention: Footwear with dorsal fixation
Number of subjects: 30
Study 27004631 — intervention group
Group type: COMPARATOR
Intervention: Slippers
Number of subjects: 30
Study 27004631 — intervention group
Group type: COMPARATOR
Intervention: Bare feet
Number of subjects: 30
Study 25130226 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-based intervention guided by social cognitive theory (SCT) including two 45-minute in-office training sessions and a dual-language communication guide.
Number of subjects: 25
Study 25130226 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 25
Study 21817954 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with Tdap and/or MCV4
Number of subjects: 1283
Study 21817954 — intervention group
Group type: COMPARATOR
Intervention: HPV-16/18 AS04-adjuvanted vaccine alone
Number of subjects: 1283
Study 21817954 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with Tdap
Number of subjects: 1283
Study 21817954 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine coadministered with MCV4
Number of subjects: 1283
Study 19328268 — intervention group
Group type: EXPERIMENTAL
Intervention: South Beach diet
Number of subjects: 18
Study 19328268 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornish diet
Number of subjects: 18
Study 19328268 — intervention group
Group type: COMPARATOR
Intervention: Atkins diet
Number of subjects: 18
Study 19328268 — intervention group
Group type: COMPARATOR
Intervention: Brachial artery testing
Number of subjects: 18
Study 17047484 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 114
Study 17047484 — intervention group
Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 114
Study 15364708 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 1200 mg/d plus vitamin A
Number of subjects: 221
Study 15364708 — intervention group
Group type: COMPARATOR
Intervention: Control capsules plus vitamin A
Number of subjects: 221
Study 11046101 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasosartan (100 mg p.o.)
Number of subjects: 12
Study 11046101 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasosartan (50 mg i.v.)
Number of subjects: 12
Study 11046101 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoltasosartan (2.5 mg i.v.)
Number of subjects: 12
Study 11046101 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro blockade by Tasosartan
Number of subjects: 12
Study 11046101 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro blockade by Enoltasosartan
Number of subjects: 12
Study 9333103 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg/day for 8 days)
Number of subjects: 12
Study 8467987 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and diet group (EXE)
Number of subjects: 41
Study 8467987 — intervention group
Group type: COMPARATOR
Intervention: Insulin and diet group (INS)
Number of subjects: 41
Study 3532592 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg cimetidine (400 mg q.i.d.) daily
Number of subjects: 323
Study 3532592 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg cimetidine (400 mg b.i.d.) daily
Number of subjects: 323
Study 30124952 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid combined with MMF therapy (1-1.5 g/day)
Number of subjects: 69
Study 30124952 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid monotherapy (0.6-0.8 mg/(kg·day) and tapered gradually)
Number of subjects: 69
Study 28858120 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave therapy (ESWT)
Number of subjects: 84
Study 28858120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 26098848 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Personalised Intervention (BPI)
Number of subjects: 103
Study 26098848 — intervention group
Group type: COMPARATOR
Intervention: Active Control (alcohol-related quiz on the UK Department of Health's Change4Life website)
Number of subjects: 103
Study 23100282 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily
Number of subjects: 18705
Study 23100282 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18705
Study 21614906 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine + acetaminophen + ketoprofen
Number of subjects: 128
Study 21614906 — intervention group
Group type: COMPARATOR
Intervention: morphine + metamizol + ketoprofen
Number of subjects: 128
Study 19802545 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingzhen Decoction (QZD)
Number of subjects: 62
Study 19802545 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine therapy only)
Number of subjects: 62
Study 16963345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received four stage-based newsletters, one motivational interview, and an individually tailored e-mail follow-up over a 4-month period.
Number of subjects: 437
Study 16963345 — intervention group
Group type: COMPARATOR
Intervention: Control group received only assessment at baseline and at completion.
Number of subjects: 437
Study 15289245 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills intervention delivered in 3 modules over 24 sessions
Number of subjects: 423
Study 15289245 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 423
Study 11346243 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinfarction angina
Number of subjects: 119
Study 11346243 — intervention group
Group type: COMPARATOR
Intervention: No preinfarction angina
Number of subjects: 119
Study 9225507 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional kinesitherapy with magnetotherapy
Number of subjects: 60
Study 9225507 — intervention group
Group type: COMPARATOR
Intervention: Conventional kinesitherapy without magnetotherapy
Number of subjects: 60
Study 8317683 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane anesthesia
Number of subjects: 40
Study 8317683 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 40
Study 8317683 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation
Number of subjects: 40
Study 8317683 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ventilation
Number of subjects: 40
Study 8317683 — intervention group
Group type: COMPARATOR
Intervention: Both enflurane and isoflurane
Number of subjects: 40
Study 3107365 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 427
Study 3107365 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 427
Study 31169888 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (3 months)
Number of subjects: 0
Study 31169888 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (post-intervention)
Number of subjects: 0
Study 29128651 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal education (MME) intervention including a structured web-course, role play exercise, WebPatientEncounter, and enhanced outpatient clerkship.
Number of subjects: 8
Study 29128651 — intervention group
Group type: COMPARATOR
Intervention: Traditional education (TE)
Number of subjects: 8
Study 29128651 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal education (MME) intervention
Number of subjects: 8
Study 27917806 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain articaine 40 mg mixed with fentanyl 20 µg
Number of subjects: 100
Study 27917806 — intervention group
Group type: COMPARATOR
Intervention: Plain levobupivacaine 10 mg mixed with fentanyl 20 µg
Number of subjects: 100
Study 24911576 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 50 mg + ethanol 0.7 g/kg
Number of subjects: 16
Study 24911576 — intervention group
Group type: COMPARATOR
Intervention: morphine 50 mg + ethanol placebo
Number of subjects: 16
Study 24911576 — intervention group
Group type: COMPARATOR
Intervention: morphine placebo + ethanol 0.7 g/kg
Number of subjects: 16
Study 24911576 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 30 mg or 80 mg (alone and in combination with ethanol)
Number of subjects: 16
Study 24911576 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine and ethanol (combined)
Number of subjects: 16
Study 22429177 — intervention group
Group type: EXPERIMENTAL
Intervention: ESPO group (expert demonstration, self-assessment, peer feedback)
Number of subjects: 0
Study 22429177 — intervention group
Group type: EXPERIMENTAL
Intervention: ESPO group
Number of subjects: 0
Study 22429177 — intervention group
Group type: COMPARATOR
Intervention: EO group (expert demonstration only)
Number of subjects: 0
Study 22429177 — intervention group
Group type: EXPERIMENTAL
Intervention: ESO group (expert demonstration, self-assessment, expert feedback)
Number of subjects: 0
Study 19887878 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg (0.1 ml) bevacizumab
Number of subjects: 30
Study 19887878 — intervention group
Group type: COMPARATOR
Intervention: 0.1 ml balanced salt solution
Number of subjects: 30
Study 18647814 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 25
Study 18647814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 17094040 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with optimal lung volume strategy (OLVS)
Number of subjects: 10
Study 17094040 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation or high-frequency oscillatory ventilation
Number of subjects: 10
Study 14641427 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledermix paste
Number of subjects: 221
Study 14641427 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste
Number of subjects: 221
Study 14641427 — intervention group
Group type: COMPARATOR
Intervention: No dressing
Number of subjects: 221
Study 10675071 — intervention group
Group type: EXPERIMENTAL
Intervention: ramipril (10 mg/day)
Number of subjects: 3577
Study 9410237 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen ED twice a day from the first preoperative day to the third postoperative day
Number of subjects: 100
Study 9410237 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears twice a day from the first preoperative day to the third postoperative day
Number of subjects: 100
Study 8460605 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified rusk
Number of subjects: 226
Study 8460605 — intervention group
Group type: COMPARATOR
Intervention: Unfortified rusk
Number of subjects: 226
Study 3987415 — intervention group
Group type: EXPERIMENTAL
Intervention: Active exposure to the Brazelton Neonatal Behavior Assessment (parents actively eliciting responses from newborns)
Number of subjects: 0
Study 3987415 — intervention group
Group type: COMPARATOR
Intervention: Passive exposure to the Brazelton Neonatal Behavior Assessment (parents listening to a verbal description of infant performance)
Number of subjects: 0
Study 31896832 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 5% spray for 8 weeks
Number of subjects: 150
Study 31896832 — intervention group
Group type: COMPARATOR
Intervention: Placebo (alcohol spray) for 8 weeks
Number of subjects: 150
Study 29653857 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX6/Bevacizumab with pelareorep (n=51)
Number of subjects: 103
Study 29653857 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX6/Bevacizumab without pelareorep (n=52)
Number of subjects: 103
Study 26525880 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2713
Study 26525880 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 2713
Study 26525880 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2713
Study 25051779 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamberin in pathogenetic therapy
Number of subjects: 0
Study 22289227 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32
Study 22289227 — intervention group
Group type: COMPARATOR
Intervention: 30-minute home exercise program
Number of subjects: 32
Study 22289227 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32
Study 22289227 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32
Study 20462826 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of BSE/CBE, marital status, educational status, knowledge of treatment of breast cancer
Number of subjects: 386
Study 20462826 — intervention group
Group type: EXPERIMENTAL
Intervention: No formal education status, being a farmer
Number of subjects: 386
Study 18338963 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal contact physical activity intervention (one group meeting, self-help booklet, five monthly reminder letters)
Number of subjects: 169
Study 18338963 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 169
Study 18338963 — intervention group
Group type: EXPERIMENTAL
Intervention: International Physical Activity Questionnaire (IPAQ)
Number of subjects: 169
Study 15805998 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 10
Study 12698399 — intervention group
Group type: EXPERIMENTAL
Intervention: Target temperature 28 degrees C
Number of subjects: 30
Study 12698399 — intervention group
Group type: COMPARATOR
Intervention: Target temperature 34 degrees C
Number of subjects: 30
Study 12698399 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of pump blood flow from 2.4 to 2.0 L/min/m(2) during hypothermia
Number of subjects: 30
Study 12698399 — intervention group
Group type: EXPERIMENTAL
Intervention: Rewarming phase
Number of subjects: 30
Study 12698399 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum concentrations of C3a and IL-6
Number of subjects: 30
Study 10476890 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Plak Control Ultra
Number of subjects: 60
Study 10476890 — intervention group
Group type: EXPERIMENTAL
Intervention: Rowenta MH700
Number of subjects: 60
Study 8760775 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release theophylline
Number of subjects: 18
Study 1887965 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study 1887965 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study 6875530 — intervention group
Group type: EXPERIMENTAL
Intervention: Life skills training
Number of subjects: 28
Study 6875530 — intervention group
Group type: COMPARATOR
Intervention: Traditional Veterans Administration rehabilitation program
Number of subjects: 28
Study 30529836 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottom-up intervention (Brain Fitness)
Number of subjects: 99
Study 30529836 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-down intervention (COGPACK)
Number of subjects: 99
Study 30529836 — intervention group
Group type: COMPARATOR
Intervention: Control condition (Sporcle - commercial computer games)
Number of subjects: 99
Study 29752001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg
Number of subjects: 666
Study 29752001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 666
Study 29752001 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 666
Study 23773886 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone Long-Acting Injectable (RLAI)
Number of subjects: 85
Study 23773886 — intervention group
Group type: COMPARATOR
Intervention: Oral second-generation antipsychotics (SGAs)
Number of subjects: 85
Study 23532306 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 34
Study 23532306 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 22152650 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCS-sweetened beverages
Number of subjects: 40
Study 22152650 — intervention group
Group type: COMPARATOR
Intervention: Sucrose-sweetened beverages
Number of subjects: 40
Study 19013235 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss program (12 weeks) followed by weight stabilization (4 weeks)
Number of subjects: 42
Study 19013235 — intervention group
Group type: COMPARATOR
Intervention: Weight maintenance (16 weeks)
Number of subjects: 42
Study 17161887 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard polymeric diet (Group S, n=8)
Number of subjects: 15
Study 17161887 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-enriched polymeric diet (Group G, n=7)
Number of subjects: 15
Study 15047035 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (20 mg)
Number of subjects: 60
Study 15047035 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (60 mg)
Number of subjects: 60
Study 15047035 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls (placebo)
Number of subjects: 60
Study 12501759 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice a day for eight weeks
Number of subjects: 20
Study 12501759 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 20
Study 9798587 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg keliximab
Number of subjects: 22
Study 9798587 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg keliximab
Number of subjects: 22
Study 9798587 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg keliximab
Number of subjects: 22
Study 9798587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7619674 — intervention group
Group type: EXPERIMENTAL
Intervention: Romazarit 200 mg every 12 h for up to 24 weeks
Number of subjects: 224
Study 7619674 — intervention group
Group type: EXPERIMENTAL
Intervention: Romazarit 450 mg every 12 h for up to 24 weeks
Number of subjects: 224
Study 7619674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 2180024 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure strength training
Number of subjects: 0
Study 2180024 — intervention group
Group type: COMPARATOR
Intervention: Functional training without specific strength training
Number of subjects: 0
Study 2180024 — intervention group
Group type: EXPERIMENTAL
Intervention: New rehabilitation programme combining pure strength training and functional training
Number of subjects: 0
Study 633026 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 15 minutes light off)
Number of subjects: 0
Study 633026 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 30 minutes light off)
Number of subjects: 0
Study 633026 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 60 minutes light off)
Number of subjects: 0
Study 633026 — intervention group
Group type: COMPARATOR
Intervention: Continuous illumination
Number of subjects: 0
Study 31698293 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication error encouragement training (MEET)
Number of subjects: 97
Study 31698293 — intervention group
Group type: COMPARATOR
Intervention: Traditional error avoidance training (Control)
Number of subjects: 97
Study 31424460 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence and symptom management group
Number of subjects: 272
Study 31424460 — intervention group
Group type: COMPARATOR
Intervention: Usual care/control group
Number of subjects: 272
Study 28720612 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective clinical team surveillance (PCTS)
Number of subjects: 7
Study 28720612 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity PCTS
Number of subjects: 7
Study 25728699 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured plaque control (powered tooth brushing and inter-dental cleaning advice)
Number of subjects: 82
Study 25728699 — intervention group
Group type: COMPARATOR
Intervention: Control (normal dental plaque control regimen)
Number of subjects: 82
Study 23665965 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 390
Study 21937959 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis Resource Management (CRM) training during a simulated patient crisis
Number of subjects: 4
Study 21937959 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Life Support plus CRM training
Number of subjects: 4
Study 21937959 — intervention group
Group type: COMPARATOR
Intervention: Basic Life Support only
Number of subjects: 4
Study 21937959 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis Resource Management (CRM) training
Number of subjects: 4
Study 20137718 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCT and SAA combined group
Number of subjects: 225
Study 20137718 — intervention group
Group type: COMPARATOR
Intervention: MSCT group
Number of subjects: 225
Study 17367478 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone/proguanil (A/P)
Number of subjects: 169
Study 15280342 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based decision aid followed by genetic counseling (n = 106)
Number of subjects: 211
Study 15280342 — intervention group
Group type: COMPARATOR
Intervention: Standard one-on-one genetic counseling (n = 105)
Number of subjects: 211
Study 15280342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (computer and counseling)
Number of subjects: 211
Study 15280342 — intervention group
Group type: COMPARATOR
Intervention: Counseling
Number of subjects: 211
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: All statins pooled
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 99
Study 11204586 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 99